Literature DB >> 34474705

Vaccine preventable diseases, vaccine hesitancy, and COVID-19: A role for the allergist/immunologist.

Joseph A Bellanti, Russell A Settipane.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 34474705      PMCID： PMC8677494          DOI： 10.2500/aap.2021.42.210070

Source DB:  PubMed          Journal:  Allergy Asthma Proc        ISSN： 1088-5412            Impact factor:   2.587


× No keyword cloud information.
  27 in total

Review 1.  Coronavirus disease 2019, allergic diseases, and allergen immunotherapy: Possible favorable mechanisms of interaction.

Authors:  Désirée E Larenas-Linnemann; José A Ortega-Martell; María V Blandón-Vijil; Noel Rodríguez-Pérez; Jorge A Luna-Pech; Alan Estrada-Cardona; Alfredo Arias-Cruz; Blanca E Del Rio-Navarro; Elsy M Navarrete Rodríguez; Cesar F Pozo-Beltrán; Ernesto Onuma Takane; María I Rojo-Gutiérrez; Francisco J Espinosa-Rosales; Eric A Martínez-Infante
Journal:  Allergy Asthma Proc       Date:  2021-05-01       Impact factor: 2.587

2.  The challenge of COVID-19 that permeates the practice of allergy/immunology.

Authors:  Joseph A Bellanti; Russell A Settipane
Journal:  Allergy Asthma Proc       Date:  2021-01-01       Impact factor: 2.587

3.  COVID-19 in children: Pathogenesis and current status.

Authors:  Lawrence D Frenkel; Fernando Gomez; Joseph A Bellanti
Journal:  Allergy Asthma Proc       Date:  2021-01-03       Impact factor: 2.587

4.  Eosinopenia could be a relevant prognostic biomarker in patients with coronavirus disease 2019.

Authors:  Stefano Perlini; Giorgio Ciprandi; Riccardo Castagnoli; Amelia Licari; Gian Luigi Marseglia
Journal:  Allergy Asthma Proc       Date:  2020-11-01       Impact factor: 2.587

5.  Caregiver perceptions and attitudes associated with oral immunotherapy on social media.

Authors:  Suzanne Kochis; Corinne Keet; Lauren E Claus; Tai Hairston; Annie R Links; Emily F Boss
Journal:  Allergy Asthma Proc       Date:  2021-09-01       Impact factor: 2.587

6.  Effect of COVID-19 on hereditary angioedema activity and quality of life.

Authors:  Ozge Can Bostan; Gulseren Tuncay; Ebru Damadoglu; Gul Karakaya; Ali Fuat Kalyoncu
Journal:  Allergy Asthma Proc       Date:  2021-09-01       Impact factor: 2.587

Review 7.  Tropomyosin: A panallergen that causes a worldwide allergic problem.

Authors:  Francesco Papia; Chiara Bellia; Carina Gabriela Uasuf
Journal:  Allergy Asthma Proc       Date:  2021-09-01       Impact factor: 2.587

8.  How important is proper dosing for subcutaneous and sublingual allergy immunotherapy?

Authors:  Harold S Nelson
Journal:  Allergy Asthma Proc       Date:  2021-09-01       Impact factor: 2.587

9.  Food-induced anaphylaxis in early childhood and factors associated with its severity.

Authors:  Metin Aydogan; Erdem Topal; Nalan Yakıcı; Hazal Cansu Acar; Zeynep Hızlı Demirkale; Mustafa Arga; Pınar Uysal; Sezin Aydemir; Isıl Eser Simsek; Zeynep Tamay; Sükrü Cekic; Ozlem Cavkaytar; Fatih Kaplan; Ayca Kıykım; Müjde Tugba Cogurlu; Ayse Süleyman; Esra Yücel; Emre Akkelle; Gonca Hancıoglu; Adem Yasar; Tuba Tuncel; Hikmet Tekin Nacaroglu; Cigdem Aydogmus; Nermin Güler; Haluk Cokugras; Nihat Sapan; Hasan Yüksel; Recep Sancak; Mehmet Sarper Erdogan; Oner Ozdemir; Cevdet Ozdemir; Fazıl Orhan
Journal:  Allergy Asthma Proc       Date:  2021-09-01       Impact factor: 2.587

10.  A 33-year-old man with a history of recurrent pneumonia presenting with hypoxemic respiratory failure.

Authors:  Taylor Eddens; Sara Van Meerbeke; Michael Zhang; Andrej Petrov; Merritt L Fajt
Journal:  Allergy Asthma Proc       Date:  2021-07-13       Impact factor: 2.587
View more
  1 in total

1.  Vaccine preventable diseases, vaccine hesitancy, and COVID-19: A role for the allergist/immunologist.

Authors:  Joseph A Bellanti; Russell A Settipane
Journal:  Allergy Asthma Proc       Date:  2021-09-01       Impact factor: 2.587
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.